Virginia AIDS Drug Assistance Program (ADAP)

ADAP provides medications for low-income, uninsured individuals with HIV/AIDS.  Due to unprecedented enrollment and increased treatment costs, ADAP is currently only open to new enrollment to individuals meeting any of the following criteria:

• All new clients with CD4 at or below 500 and previously wait-listed clients with a reported CD4 count at or below 500.
• Pregnant women
• 18 years old or younger (includes perinatally-exposed newborns)
• Individuals receiving treatment for an active opportunistic infection.

Virginia ADAP continues to serve more than 2400 clients who remain in the program. ADAP is one of several HIV/AIDS medication resources of its kind. Other like sources includes Medicaid, patient assistance programs and private insurance companies.

For more information about changes to ADAP, please visit our Update Page.

Clinical Support and Policy Development

In 1996, an ADAP Advisory Committee was created. The committee is comprised of HIV/AIDS medical providers, a pharmacist, and consumers. The committee advises VDH on changes to the formulary, changes in eligibility criteria, adherence issues, and educational concerns. The committee reviews data on ADAP utilization and assess budgetary implications of trends and program changes.

Questions or comments?

Contact HIV/STD/Viral Hepatitis Hotline